LifeStance Health Group, Inc. (LFST)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 345,311 | 332,970 | 312,722 | |
| Other general expense | - | - | 212,291 | |
| General and administrative expenses | 97,375 | 94,431 | 85,269 | |
| Depreciation and amortization | 14,006 | 13,756 | 15,115 | |
| Center costs, excluding depreciation and amortization shown separately below | 236,880 | 223,179 | - | |
| Total operating expenses | 348,261 | 331,366 | 312,675 | |
| Loss from operations | -2,950 | 1,604 | 47 | |
| Other expense | 92 | 1 | 2 | |
| Interest expense, net | 2,900 | 3,073 | 5,413 | |
| Transaction costs | - | - | 29 | |
| (loss) gain on remeasurement of contingent consideration | - | - | 15 | |
| Total other expense | -2,992 | -3,074 | -5,429 | |
| Loss before income taxes | -5,942 | -1,470 | -5,382 | |
| Income tax benefit (provision) | -2,151 | -2,179 | 575 | |
| Net loss | -3,791 | 709 | -5,957 | |
| Unrealized (losses) gains on cash flow hedge, net of tax | -267 | -317 | -1,872 | |
| Comprehensive loss | -4,058 | 392 | -7,829 | |
| Weighted average number of shares outstanding, basic | 386,733,000 | 383,272,000 | 380,359,000 | |
| Weighted average number of shares outstanding, diluted | 386,733,000 | 390,666,000 | 380,359,000 | |